interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Elacestrant Hydrochloride

Generic competition · all medicines · read 12 November 2026

Is there a generic of Elacestrant Hydrochloride, and who makes it?

Elacestrant Hydrochloride appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Elacestrant Hydrochloride1 dosage-form group in the Orange Book
0generic makers listed
  1. Elacestrant Hydrochloride appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Orserdu. No generic is listed as marketed.

2020202520302035204001brand 2023data datePatent 10071066 listed to expire 10 October 2034Patent 11779552 listed to expire 10 October 2034Patent 10420734 listed to expire 3 October 2036Patent 11819480 listed to expire 28 February 2037Patent 10745343 listed to expire 5 January 2038Patent 10385008 listed to expire 5 January 2038Exclusivity NCE to 27 January 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 27 January 2028Exclusivity NCE Orserdu
  • 10 October 2034Patent 10071066
  • 10 October 2034Patent 11779552
  • 3 October 2036Patent 10420734
  • 28 February 2037Patent 11819480
  • 5 January 2038Patent 10745343
  • 5 January 2038Patent 10385008 drug substance

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.